Charline Duquenne

Title: Charline Duquenne: Innovator in ERK Kinase Inhibitors

Introduction

Charline Duquenne is a prominent inventor based in Saint Bres, France. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that act as inhibitors of ERK kinase activity. With a total of 2 patents to her name, her work is paving the way for advancements in therapeutic applications.

Latest Patents

Charline's latest patents include innovative compounds known as Azaindole derivatives and their use as ERK kinase inhibitors. The first patent concerns a compound of formula (I), or one of its pharmaceutically acceptable salts, specifically designed to inhibit ERK kinase activity, particularly ERK2 activity. Additionally, it addresses prodrugs of these compounds. The second patent focuses on Zaindole derivatives, which also serve as ERK kinase inhibitors, emphasizing their potential in medical applications.

Career Highlights

Throughout her career, Charline has worked with notable organizations such as Agv Discovery and the Institut National de la Santé et de la Recherche Médicale. Her experience in these institutions has allowed her to collaborate on groundbreaking research and development projects.

Collaborations

Charline has collaborated with esteemed colleagues, including Jean-François Guichou and Cédric Bories. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Charline Duquenne is a trailblazer in the field of ERK kinase inhibitors, with her innovative patents showcasing her expertise and dedication. Her contributions are vital to the ongoing research in medicinal chemistry and hold promise for future therapeutic developments.